How CAR T-cell Therapy Saved My Life: Chuck’s Story

Chuck Colletti On this episode, Alicia and Lizette speak with Chuck Colletti, a two-time survivor of Stage 4 follicular lymphoma. Chuck was diagnosed in early 2016 when he underwent 7 months of chemotherapy which put his cancer into temporary remission. Unfortunately, 7 months later, it returned in a more aggressive form. With options dwindling, he was accepted into a CAR T-cell therapy clinical trial. Listen in as he describes how this therapy impacted his life both emotionally and physically, the side effects he experienced and the hope he has in this therapy’s ability to save many more lives. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Chimeric Antigen Receptor (CAR) T-Cell Therapywww.collettisurvivorsquad.orgwww.healthcentral.com Additional LLS Support Resources: Chimeric Antigen Receptor (CAR) T-Cell Therapy FactsCAR T-Cell Therapy ProcessVideos about CAR T-cell therapyInformation SpecialistsFree telephone/web patient programsFree bookletsFinancial supportOnline chatsCaregiver supportLLS CommunitySupport groups Support for this episode provided by Celgene; Kite, A Gilead Company; and Novartis Oncology.The post How CAR T-cell Therapy Saved My Life: Chuck’s Story first appeared on The Bloodline with Blood Cancer United Podcast.